It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...

Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...

Impacts of tariffs on the pharmaceutical industry, cutting-edge container monitoring and the sheer number of chicken wings ...

Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

Top Republican recipients of contributions from employees or PACS associated with the pharmaceutical/health products ...

In a statement sent to Pharmaceutical Executive, AMCP CEO Susan A. Cantrell, MHL, RPh, CAE, said, “Although President Trump’s ...

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...

CNN visits several African companies on the forefront of boosting vaccine and medical supply manufacturing across the ...

Entering 2025, the CDMO industry is at a crossroads. Reflecting on conversations over the past year—with CEOs navigating ...